ID: ALA124858

Max Phase: Preclinical

Molecular Formula: C9H15N3O2

Molecular Weight: 197.24

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)CCNc1cc(O)nc(O)n1

Standard InChI:  InChI=1S/C9H15N3O2/c1-6(2)3-4-10-7-5-8(13)12-9(14)11-7/h5-6H,3-4H2,1-2H3,(H3,10,11,12,13,14)

Standard InChI Key:  MALQURSGXLGIBR-UHFFFAOYSA-N

Associated Targets(non-human)

DNA topoisomerase III 145 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 197.24Molecular Weight (Monoisotopic): 197.1164AlogP: 1.35#Rotatable Bonds: 4
Polar Surface Area: 78.27Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.75CX Basic pKa: 1.52CX LogP: 2.39CX LogD: 2.38
Aromatic Rings: 1Heavy Atoms: 14QED Weighted: 0.68Np Likeness Score: -0.84

References

1. Wright GE, Brown NC..  (1980)  Inhibitors of Bacillus subtilis DNA polymerase III. 6-Anilinouracils and 6-(alkylamino)uracils.,  23  (1): [PMID:6767030] [10.1021/jm00175a007]

Source